Trials / Completed
CompletedNCT03147391
Left Atrial Appendage Closure With the LAmbre
Percutaneous Left Atrial Appendage Closure Using the LAmbre Device in Patients With Atrial Fibrillation: a Single-center, Retrospective, Long-term Real-world Study
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 66 (actual)
- Sponsor
- Shanghai 10th People's Hospital · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The study was to retrospectively analyse the efficacy and safety of LAA closure using the LAmbre in our center from April 2014 to November 2015.
Detailed description
The study was to retrospectively analyse the efficacy and safety of percutaneous left atrial appendage (LAA) closure using the LAmbre (Lifetech Scientific Co., Ltd., Shenzhen, China) in our center from April 2014 to November 2015. 89.4% has finished the 12-month esophageal ecllocardiogrhy (TEE) examination. The average followup was 2-years.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | LAA closure with LAmbre | Percutaneous Left Atrial Appendage Closure Using the LAmbre Device in Patients With Atrial Fibrillation |
Timeline
- Start date
- 2014-04-14
- Primary completion
- 2016-11-30
- Completion
- 2017-05-01
- First posted
- 2017-05-10
- Last updated
- 2017-05-10
Source: ClinicalTrials.gov record NCT03147391. Inclusion in this directory is not an endorsement.